Last $0.16 USD
Change Today +0.0025 / 1.59%
Volume 1.0K
BIEI On Other Exchanges
Symbol
Exchange
OTC BB
As of 8:10 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

premier biomedical inc (BIEI) Snapshot

Open
$0.16
Previous Close
$0.16
Day High
$0.16
Day Low
$0.16
52 Week High
03/3/14 - $1.17
52 Week Low
10/16/14 - $0.06
Market Cap
3.5M
Average Volume 10 Days
7.3K
EPS TTM
--
Shares Outstanding
21.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PREMIER BIOMEDICAL INC (BIEI)

Related News

No related news articles were found.

premier biomedical inc (BIEI) Related Businessweek News

No Related Businessweek News Found

premier biomedical inc (BIEI) Details

Premier Biomedical, Inc., a research-based company, develops and markets medications and procedures for health issues worldwide. It develops sequential-dialysis technique for the treatment of alzheimer’s disease, amyotrophic lateral sclerosis, blood sepsis and viremia, leukemia, and other life-threatening cancers; and Feldetrex, a drug candidate for multiple sclerosis, fibromyalgia, and traumatic brain injury. The company markets its products to pharmaceutical firms directly, as well as through publication in medical journals. It has a collaborative agreement with the University of Texas at El Paso to develop a series of research and development programs for its sequential-dialysis technology in the areas of alzheimer's disease, traumatic brain injury, chronic pain syndrome, fibromyalgia, multiple sclerosis, amyotrophic lateral sclerosis, blood sepsis, cancer, heart attacks, and strokes. The company was founded in 2010 and is based in El Paso, Texas.

premier biomedical inc (BIEI) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: --
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

premier biomedical inc (BIEI) Key Developments

Premier Biomedical, Inc. announced delayed 10-Q filing

On 11/14/2014, Premier Biomedical, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Premier Biomedical, Inc. Adds Patricio F. Reyes to Scientific Advisory Board

Premier Biomedical, Inc. announced the addition of Dr. Patricio F. Reyes to their Scientific Advisory Board effective immediately. Dr. Reyes will report to the Chairman of the Scientific Advisory Board and co-founder of the Corporation, Dr. Mitchell S. Felder, MD, and to the President and CEO, William A. Hartman. Dr. Reyes is a board member, and former Chair of the Education Committee. Dr. Reyes is a co-founder, Chief Medical Officer and Chair of the Scientific Advisory Board of Yuma Therapeutics, Inc.

Premier Biomedical Announces Addition of K. Adam Dubov to Scientific Advisory Board

Premier Biomedical, Inc. announced the addition of K. Adam Dubov to their Scientific Advisory Board effective immediately. Mr. Dubov will report to the Chairman of the Scientific Advisory Board, and co-founder of the Corporation, Dr. Mitchell S. Felder, MD, and to the President and CEO, William A. Hartman. Mr. Dubov, an FDA (Food & Drug Administration) Regulatory Expert, has extensive experience with FDA processes for all phases of clinical trials or marketing approval from the FDA. He has been involved with both U.S. military and civilian applications related to the review and submissions for approval of clinical trials for drugs (Investigational New Drugs, Abbreviated New Drug Applications), devices (Non-Significant Risk, Investigational Device Exemptions), biologics (Biological Investigational New Drugs, and biosimilars), combination products, and other articles regulated by the FDA.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIEI:US $0.16 USD +0.0025

BIEI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BIEI.
View Industry Companies
 

Industry Analysis

BIEI

Industry Average

Valuation BIEI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 301.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PREMIER BIOMEDICAL INC, please visit www.premierbiomedicalinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.